Axial Spondyloarthritis - Opportunity Analysis and Forecast to 2024

Claire Herman, MPH is Global Director of Therapy Analysis and Epidemiology at GlobalData in Boston. She has more than 15 years of experience in the healthcare industry, during which she has led teams in the development and delivery of industry-leading competitive intelligence product offerings. Claire began her career at Decision Resources, where she worked as an Analyst and Epidemiologist evaluating disease markets across therapeutic areas, assessing the potential of pipeline drugs in the context of current medical practice, and developing patient-based prescription drug sales forecasts. Prior to her current role, Claire was the Director of Autoimmune/Inflammation, CNS, and Ophthalmology for Citeline/Informa’s Trialtrove database, where she managed her team’s daily operations and was involved in various product enhancement initiatives. Previously, she was a Manager in Citeline’s consulting division, where she developed customized analyses of the clinical trials competitive landscape. Claire holds a Bachelor’s degree from Wellesley College and a Master of Public Health degree in epidemiology from Boston University.

Heather Leach, PhD, is the Director of Immunology at GlobalData in Boston. Heather has 10 years of basic research experience in molecular biology and immunology and over five years experience as an analyst and consultant for the biopharmaceutical industry. Previously, Heather served as GlobalData’s Director of Oncology and Hematology. Prior to joining GlobalData’s oncology group, she worked as an analyst in both immunology and neurology, and as a consultant for a boutique life sciences consulting firm in New York City. She has worked in various academic and pharmaceutical research labs at the University of Connecticut, Boston University School of Medicine, and Pfizer, covering human diseases such as sepsis, systemic sclerosis, and idiopathic pulmonary fibrosis. Heather holds a Bachelor’s degree in Molecular and Cell Biology from the University of Connecticut, and a PhD in Pathology and Cell and Molecular Biology from Boston University School of Medicine.

Kasey Fu, MPH, is the Director of Epidemiology at GlobalData in Boston, where her primary responsibilities include producing descriptive and analytical epidemiological reports for major drug indications, monitoring and maintaining the company’s state-of-the-art epidemiology database, liaising with other company units in developing new products, and completing global consulting projects. Prior to joining GlobalData, Kasey worked as a Wilbur G. Downs Global Health Fellow at the Instituto Nacional de Salud of Colombia analyzing dengue epidemic trends, risk factors, and the effects of climate change using multivariate regression and spatial modeling. She also worked as a staff writer for the Yale-Tulane Virtual Medical Operations Center producing public health and epidemiology reports for US military operations and international aid efforts during catastrophic disasters. Kasey holds a Master of Public Health in the Epidemiology of Microbial Diseases from the Yale School of Public Health. She is also fluent in Chinese and proficient in Spanish.